Journal list menu
Export Citations
Download PDFs
Cover Image
Issue Information
Hepatology Highlights
Editorials
Free Access
free
Regression of HCV cirrhosis: Time will tell
- Pages: 1651-1653
- First Published: 09 December 2017
Free Access
free
Bringing the cell nucleus in the focus of NAFLD
- Pages: 1654-1656
- First Published: 01 December 2017
Free Access
free
Nonalcoholic fatty liver disease, metabolic syndrome, and the fight that will define clinical practice for a generation of hepatologists
- Pages: 1657-1659
- First Published: 09 December 2017
Free Access
free
Pyroptosis, A novel player for alcoholic hepatitis?
- Pages: 1660-1662
- First Published: 09 December 2017
Free Access
free
Breaking Kuhn's paradigm in advanced hepatocellular carcinoma
- Pages: 1663-1665
- First Published: 08 December 2017
Free Access
free
Evolving role of obeticholic acid in primary biliary cholangitis
- Pages: 1666-1668
- First Published: 09 December 2017
Introducing the AASLD President
Free Access
free
Introducing Ronald J. Sokol, M.D.—our 2018 AASLD president
- Pages: 1669-1672
- First Published: 21 February 2018
Rapid Communication
Free Access
free
Hepatitis C transmission from seropositive, nonviremic donors to non–hepatitis C liver transplant recipients
- Pages: 1673-1682
- First Published: 02 December 2017
Original Articles
VIRAL HEPATITIS
Free Access
free
Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C
- Pages: 1683-1694
- First Published: 27 September 2017
Free Access
free
Global microRNA expression profiling in the liver biopsies of hepatitis B virus–infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury
- Pages: 1695-1709
- First Published: 30 November 2017
STEATOHEPATITIS/METABOLIC LIVER DISEASE
Free Access
free
Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease
- Pages: 1710-1725
- First Published: 13 September 2017
Free Access
free
Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study
- Pages: 1726-1736
- First Published: 23 September 2017
Free Access
free
Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients
- Pages: 1737-1753
- First Published: 06 November 2017
Open Access
oa
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- Pages: 1754-1767
- First Published: 17 August 2017
Free Access
free
Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis
- Pages: 1768-1783
- First Published: 15 November 2017
HEPATOBILIARY MALIGNANCIES
Free Access
free
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice
- Pages: 1784-1796
- First Published: 21 November 2017
Free Access
free
Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies
- Pages: 1797-1806
- First Published: 20 November 2017
Free Access
free
β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET
- Pages: 1807-1822
- First Published: 20 November 2017
Free Access
free
High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis
- Pages: 1823-1841
- First Published: 17 November 2017
Free Access
free
Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness
- Pages: 1842-1856
- First Published: 20 November 2017
Free Access
free
C/EBPα-dependent preneoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer
- Pages: 1857-1871
- First Published: 21 November 2017
Free Access
free
Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial–mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment
- Pages: 1872-1889
- First Published: 23 November 2017
AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE
Open Access
oa
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
- Pages: 1890-1902
- First Published: 10 October 2017
Free Access
free
β-Catenin and interleukin-1β–dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis
- Pages: 1903-1919
- First Published: 15 November 2017
Free Access
free
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history
- Pages: 1920-1930
- First Published: 08 December 2017
LIVER FAILURE/CIRRHOSIS/PORTAL HYPERTENSION
Free Access
free
Bleeding complications in acute liver failure
- Pages: 1931-1942
- First Published: 01 December 2017
LIVER INJURY/REGENERATION
Free Access
free
CD36 deficiency attenuates immune-mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10
- Pages: 1943-1955
- First Published: 08 December 2017
Free Access
free
Decellularized human placenta supports hepatic tissue and allows rescue in acute liver failure
- Pages: 1956-1969
- First Published: 06 December 2017
LIVER BIOLOGY/PATHOBIOLOGY
Free Access
free
B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury
- Pages: 1970-1985
- First Published: 03 November 2017
Free Access
free
Extracellular vesicles from mice with alcoholic liver disease carry a distinct protein cargo and induce macrophage activation through heat shock protein 90
- Pages: 1986-2000
- First Published: 18 December 2017
Special Article
Open Access
oa
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
- Pages: 2001-2012
- First Published: 23 October 2017
Reviews
Free Access
free
New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases
- Pages: 2013-2024
- First Published: 30 November 2017
Free Access
free
Advance care planning (ACP) for specialists managing cirrhosis: A focus on patient-centered care
- Pages: 2025-2040
- First Published: 18 December 2017
Hepatology Elsewhere
Free Access
free
Exercise alters the hepatic immunophenotype to protect against inflammatory liver disease
- Pages: 2041-2043
- First Published: 16 November 2017
Free Access
free
The role of genetics in hepatic fibrosis among hepatitis C virus patients
- Pages: 2043-2045
- First Published: 20 November 2017
Free Access
free
Scratching the surface of cholestatic itch treatments
- Pages: 2045-2048
- First Published: 01 December 2017
Clinical Observations in Hepatology
Free Access
free
Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure
- Pages: 2049-2050
- First Published: 20 November 2017
Free Access
free
Acute acalculous cholecystitis during zika virus infection in an immunocompromised patient
- Pages: 2051-2054
- First Published: 24 November 2017
Correspondence
Free Access
free
Targeting mitochondrial pyruvate carrier in nonalcoholic steatohepatitis: Growing evidence and future challenges
- Page: 2055
- First Published: 20 March 2017
Free Access
free
Mesenchymal stromal cells in treatment of acute-on-chronic liver failure
- Pages: 2056-2057
- First Published: 20 November 2017
Free Access
free
Who should receive endoscopic variceal ligation after recovering from acute variceal bleeding?
- Pages: 2057-2058
- First Published: 24 November 2017
Free Access
free
A novel frailty index improves risk prediction of waitlist mortality over the model for end-stage liver disease score alone
- Page: 2059
- First Published: 29 January 2018
Free Access
free
Von Willebrand factor for the liver: Friend or foe?
- Page: 2061
- First Published: 29 January 2018